Xenon Pharmaceuticals Inc. Common Shares Earnings Dividend
Earnings Summary
Net Profits | $-110.74Mn |
Xenon Pharmaceuticals Inc. Common Shares’s net profit fell -30.73% since last year same period to $-110.74Mn in the Q2 2026. On a quarterly growth basis, Xenon Pharmaceuticals Inc. Common Shares has generated -8.24% fall in its net profits since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.16 |
EPS Estimate Current Year | -1.16 |
Xenon Pharmaceuticals Inc. Common Shares’s earning per share (EPS) estimates for the current quarter stand at -1.16 - a 3.33% jump from last quarter’s estimates.
Xenon Pharmaceuticals Inc. Common Shares’s earning per share (EPS) estimates for the current year stand at -1.16.
Key Ratios
Earning Per Share (EPS) | -1.11 |
Xenon Pharmaceuticals Inc. Common Shares’s earning per share (EPS) fell -3.74% since last year same period to -1.11 in the Q2 2026. This indicates that the Xenon Pharmaceuticals Inc. Common Shares has generated -3.74% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-08-06 | -1.16 | -1.11 | 4.31% |
2026-05-07 | -1.2 | -1.17 | 2.5% |
